News
Tonix Pharmaceuticals (NASDAQ: TNXP) has appointed Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations. Hand brings dec ...
Served on Celgene's Executive Committee and played a key leadership role in the BMS transaction, the integration of Celgene into BMS, and the divestiture of Otezla® to Amgen Appointment marks a key ...
Triptans are contraindicated in patients with cardiovascular diseases and hypertension. Sumatriptan and others are contraindicated in patients taking monoamine oxidase (MAO) inhibitors or within 2 ...
Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully-integrated biopharmaceutical company, announced financial results for the first quarter of 2025 and re ...
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Sumatriptan 85 mg, in a rapidly dissolving form, with naproxen sodium 500 mg in a bilayer tablet, was approved as a combination tablet for the acute treatment of migraine by the US FDA on Apr 15 ...
Q. My brother is approaching 81 and is having difficulties with his memory. His doctor has prescribed donepezil.
WHEN a migraine hits, most of us make a beeline for a dark room and hope the painkillers kick in fast. But what if popping ...
FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Annou ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results